Global Canine Atopic Dermatitis Market by Mode Of Administration (Oral, Topical), by Distribution Channel (Retail, E-commerce) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028
No. Of Pages: 229
Pub. Date: 2021-10-21
TABLE OF CONTENT
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Canine Atopic Dermatitis Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Canine Atopic Dermatitis Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Canine Atopic Dermatitis Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Canine Atopic Dermatitis Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Canine Atopic Dermatitis Market Size & Forecast, 2018-2028
4.5.1 Canine Atopic Dermatitis Market Size and Y-o-Y Growth
4.5.2 Canine Atopic Dermatitis Market Absolute $ Opportunity
Chapter 5 Global Canine Atopic Dermatitis Market Analysis and Forecast by Mode Of Administration
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Mode Of Administration
5.1.2 Basis Point Share (BPS) Analysis by Mode Of Administration
5.1.3 Absolute $ Opportunity Assessment by Mode Of Administration
5.2 Canine Atopic Dermatitis Market Size Forecast by Mode Of Administration
5.2.1 Oral
5.2.2 Topical
5.3 Market Attractiveness Analysis by Mode Of Administration
Chapter 6 Global Canine Atopic Dermatitis Market Analysis and Forecast by Distribution Channel
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Distribution Channel
6.1.2 Basis Point Share (BPS) Analysis by Distribution Channel
6.1.3 Absolute $ Opportunity Assessment by Distribution Channel
6.2 Canine Atopic Dermatitis Market Size Forecast by Distribution Channel
6.2.1 Retail
6.2.2 E-commerce
6.3 Market Attractiveness Analysis by Distribution Channel
Chapter 7 Global Canine Atopic Dermatitis Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Canine Atopic Dermatitis Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Canine Atopic Dermatitis Analysis and Forecast
9.1 Introduction
9.2 North America Canine Atopic Dermatitis Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Canine Atopic Dermatitis Market Size Forecast by Mode Of Administration
9.6.1 Oral
9.6.2 Topical
9.7 Basis Point Share (BPS) Analysis by Mode Of Administration
9.8 Absolute $ Opportunity Assessment by Mode Of Administration
9.9 Market Attractiveness Analysis by Mode Of Administration
9.10 North America Canine Atopic Dermatitis Market Size Forecast by Distribution Channel
9.10.1 Retail
9.10.2 E-commerce
9.11 Basis Point Share (BPS) Analysis by Distribution Channel
9.12 Absolute $ Opportunity Assessment by Distribution Channel
9.13 Market Attractiveness Analysis by Distribution Channel
Chapter 10 Europe Canine Atopic Dermatitis Analysis and Forecast
10.1 Introduction
10.2 Europe Canine Atopic Dermatitis Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Canine Atopic Dermatitis Market Size Forecast by Mode Of Administration
10.6.1 Oral
10.6.2 Topical
10.7 Basis Point Share (BPS) Analysis by Mode Of Administration
10.8 Absolute $ Opportunity Assessment by Mode Of Administration
10.9 Market Attractiveness Analysis by Mode Of Administration
10.10 Europe Canine Atopic Dermatitis Market Size Forecast by Distribution Channel
10.10.1 Retail
10.10.2 E-commerce
10.11 Basis Point Share (BPS) Analysis by Distribution Channel
10.12 Absolute $ Opportunity Assessment by Distribution Channel
10.13 Market Attractiveness Analysis by Distribution Channel
Chapter 11 Asia Pacific Canine Atopic Dermatitis Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Canine Atopic Dermatitis Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Canine Atopic Dermatitis Market Size Forecast by Mode Of Administration
11.6.1 Oral
11.6.2 Topical
11.7 Basis Point Share (BPS) Analysis by Mode Of Administration
11.8 Absolute $ Opportunity Assessment by Mode Of Administration
11.9 Market Attractiveness Analysis by Mode Of Administration
11.10 Asia Pacific Canine Atopic Dermatitis Market Size Forecast by Distribution Channel
11.10.1 Retail
11.10.2 E-commerce
11.11 Basis Point Share (BPS) Analysis by Distribution Channel
11.12 Absolute $ Opportunity Assessment by Distribution Channel
11.13 Market Attractiveness Analysis by Distribution Channel
Chapter 12 Latin America Canine Atopic Dermatitis Analysis and Forecast
12.1 Introduction
12.2 Latin America Canine Atopic Dermatitis Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Canine Atopic Dermatitis Market Size Forecast by Mode Of Administration
12.6.1 Oral
12.6.2 Topical
12.7 Basis Point Share (BPS) Analysis by Mode Of Administration
12.8 Absolute $ Opportunity Assessment by Mode Of Administration
12.9 Market Attractiveness Analysis by Mode Of Administration
12.10 Latin America Canine Atopic Dermatitis Market Size Forecast by Distribution Channel
12.10.1 Retail
12.10.2 E-commerce
12.11 Basis Point Share (BPS) Analysis by Distribution Channel
12.12 Absolute $ Opportunity Assessment by Distribution Channel
12.13 Market Attractiveness Analysis by Distribution Channel
Chapter 13 Middle East & Africa (MEA) Canine Atopic Dermatitis Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Canine Atopic Dermatitis Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Canine Atopic Dermatitis Market Size Forecast by Mode Of Administration
13.6.1 Oral
13.6.2 Topical
13.7 Basis Point Share (BPS) Analysis by Mode Of Administration
13.8 Absolute $ Opportunity Assessment by Mode Of Administration
13.9 Market Attractiveness Analysis by Mode Of Administration
13.10 Middle East & Africa (MEA) Canine Atopic Dermatitis Market Size Forecast by Distribution Channel
13.10.1 Retail
13.10.2 E-commerce
13.11 Basis Point Share (BPS) Analysis by Distribution Channel
13.12 Absolute $ Opportunity Assessment by Distribution Channel
13.13 Market Attractiveness Analysis by Distribution Channel
Chapter 14 Competition Landscape
14.1 Canine Atopic Dermatitis Market: Competitive Dashboard
14.2 Global Canine Atopic Dermatitis Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Zoetis launched its blockbuster drug Apoquel in China to gain regional revenue share
14.3.2 in February 2019
14.3.3 Elanco
14.3.4 Virbac
14.3.5 Toray Industries Extensive product pipeline by some new industry players such as Kindred Biosciences
14.3.6 acquisitions
14.3.7 regional expansion
14.3.8 launch of new products are being adopted by the players to maintain their share For instance
14.3.9 AB Science is expected to bolster the market in the coming years Strategies such as mergers
